Suah Park
Family · Lakewood, WANPI 1316563091
Payments from drug & device makers
Across 251 payments — averaging $20.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Orexo US, Inc.$639
- Nestle Healthcare Nutrition Inc.$461
- AstraZeneca$426
- Boehringer Ingelheim$209
- Lilly USA, LLC$148
- plus $1K from 28 others
What the payments were for
- Food & beverage$5,02697%
- Education$842%
- Other$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 94 | $1,853 |
| Orexo US, Inc. | 44 | $639 |
| Nestle Healthcare Nutrition Inc. | 14 | $461 |
| AstraZeneca(2 entities) | 19 | $426 |
| Boehringer Ingelheim | 9 | $209 |
| Lilly USA, LLC | 9 | $148 |
| Medtronic | 4 | $142 |
| GSK | 5 | $101 |
| Amarin Pharma, Inc. | 4 | $92 |
| Bayer | 4 | $88 |
| Astellas Pharma US Inc | 2 | $88 |
| Phathom Pharmaceuticals, Inc. | 4 | $85 |
| Pfizer | 4 | $78 |
| Amgen | 3 | $71 |
| Abbott | 2 | $68 |
| Gilead | 3 | $57 |
| Viatris Specialty LLC | 3 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $48 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| Ascensia Diabetes Care US Inc. | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Idorsia Pharmaceuticals US Inc | 2 | $40 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Johnson & Johnson | 1 | $23 |
| Alkermes, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Braeburn Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Edwards Lifesciences | 1 | $19 |
| Shield Therapeutics Inc | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,159 in reported general payments places this provider in the 95th percentile of 1,706 family providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 146 | $286,609 |
| JardianceEmpagliflozin | 83 | $87,213 |
| FarxigaDapagliflozin Propanediol | 36 | $46,587 |
| XareltoRivaroxaban | 35 | $45,726 |
| LinzessLinaclotide | 70 | $44,830 |
| OzempicSemaglutide | 34 | $36,237 |
| TrulicityDulaglutide | 22 | $34,620 |
| JanuviaSitagliptin Phosphate | 26 | $25,963 |
| EliquisApixaban | 24 | $25,555 |
| VascepaIcosapent Ethyl | 26 | $20,514 |
| JanumetSitagliptin Phos/Metformin Hcl | 21 | $20,510 |
| MounjaroTirzepatide | 14 | $15,410 |
| Lidocaine | 128 | $12,645 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 50 | $6,330 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 42 | $5,983 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $1,853 | $331,439216 claims |
| Boehringer IngelheimJardiance | $209 | $87,21383 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $148 | $50,03036 claims |
| AstraZenecaFarxiga | $426 | $46,58736 claims |
| Johnson & JohnsonXarelto | $23 | $45,72635 claims |
| PfizerEliquis | $78 | $25,55524 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,706 family providers in Washington.
Other family in Lakewood
- Patric SchineCentralia$842K
- Sharla PetersonKenmore$192K
- Zelda SwainSpokane$83K
- Savannah MorganRenton$76K
- Kevan PettersonSeattle$56K
- Kelly McFeeSunnyside$42K
- Cheryl SomersSpokane$31K
- Hye-Jin GehringBellevue$30K
- Kaitlin BrasierSeattle$29K
- Karen JohnsonSeattle$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.